Gold Shield Group TV Spot, 'Type-2 Diabetes Medication Side Effects'
Get Free Access to the Data Below for 10 Ads!
- National Airings
- 🔒
- First Airing
- 🔒
- Last Airing
- 🔒
- Creatives
- 🔒
- Recently Aired On
- 🔒
- Est. Spend
- 🔒
- TV Impressions
- 🔒
- National Impressions
- 🔒
- Local Impressions
- 🔒
There's a Better Way to Measure TV & Streaming Ad ROI
- Real-Time Ad Measurement Across Linear and CTV
- TV Ad Attribution & Benchmarking
- Marketing Stack Integrations and Multi-Touch Attribution
- Real-Time Video Ad Creative Assessment
Gold Shield Group announces that various medications such as Invokana, Invokamet, Jardiance and Farxiga are linked to an increased risk of toe, leg and foot amputations. Type-2 Diabetics who suffered serious side effects after taking these medications are encouraged to call and file a claim.
- Published
- April 19, 2019
- Advertiser
- Gold Shield Group
- Songs
- None have been identified for this spot
- Phone
- 888-435-7861
- Mood
- Informational
- Actors - Add
- None have been identified for this spot.
-
Have questions about this ad or our catalog? Check out our FAQ Page.
- Screenshots
-
-
Screenshot
×
